The Himalaya Drug Company’s Liv.52, a phyto-pharmaceutical formulation for the management of liver disorders, will feature in the Limca Book of Records: Business Edition (2013) as the highest selling herbal drug in India, both in terms of units and rupee value. Since its launch in 1955, Liv.52 has become the country’s top hepatoprotective.
“Currently a Rs 150-crore brand, it is the only herbal drug to feature in the top ten of the bestselling drugs in India, according a report by Indian Pharmaceutical Market (IPM),” said Philipe Haydon, CEO—Pharmaceutical Division, The Himalaya Drug Company. Talking about the promotional route for Liv.52, Haydon elaborated, “Like all our pharma products, Liv.52 is also promoted ethically through doctor prescription. Currently, over 400,000 doctors across the globe prescribe Himalaya’s products,”
Over the years, Himalaya has expanded the Liv.52 brand and developed medicines for other liver ailments. A double strength formulation, Liv.52 DS, recommended in drug-induced hepatitis and early cirrhotic conditions was introduced in 1996.
On receiving the certificate from the Limca Book of Records, Haydon added, “Liv.52 has been our flagship brand since 1955 and we are thrilled with this honour. The success of Liv.52 tells us that today herbal medicine is gaining global acceptance and when combined with allopathic therapies, it can vastly improve patients’ quality of life.”
EP News Bureau
- Advertisement -
